Targeting aberrant learning may improve Parkinson's treatment

Northwestern Medicine scientists have discovered that targeting neuronal signaling controlling aberrant learning in the ...
Cancer Therapy Advisor

Enhertu Plus Pertuzumab Approved for First-Line HER2+ Breast Cancer

Patients should be selected for treatment with Enhertu in combination with pertuzumab based on confirmed HER2-positive status or HER2 gene amplification (IHC 3+ or ISH+).
Monthly Prescribing Reference

Fecal Microbiota Transplantation Could Be First-Line Therapy for C. Difficile

Clinical cure and no disease recurrence within 60 days without additional treatment was observed in 66.7% of 51 patients receiving FMT vs 61.2% of 49 patients receiving vancomycin. HealthDay News — ...
MedPage Today

A New Standard in First-Line Therapy for HER2-Positive Breast Cancer?

In the DESTINY-Breast09 trial, presented at this year's American Society of Clinical Oncology (ASCO) annual meeting, first-line trastuzumab deruxtecan (T-DXd; Enhertu) combined with pertuzumab ...
Healio

First-line immunotherapy underutilized in kidney cancer; ‘different mechanisms’ needed

Please provide your email address to receive an email when new articles are posted on . Immune checkpoint inhibitor-based combinations are the preferred first-line therapy for metastatic clear cell ...